CYP1A1 and breast carcinoma: Consistent with other investigators' observations in breast cancer cells, we observed the recruitment of AHR and ARNT on the human CYP1A1 enhancer in a TCDD-dependent fashion and ERα was greatly enriched only after treatment with a combination of 2 nM TCDD and 10 nM E2 (Figure 1A).